NORTHWEST BIOTHERAPEUTICS INC

NWBO · OTC · SIC 2834: Pharmaceutical Preparations
460
SEC Filings

Business Summary

Northwest Biotherapeutics is a biotechnology company developing personalized immune therapies for cancer using its DCVax platform technology. DCVax uses activated dendritic cells to mobilize a patient's own immune system against cancer. Its lead product, DCVax-L, targets operable solid tumors including glioblastoma multiforme (GBM). The company completed a 331-patient Phase III trial for GBM, published results in JAMA Oncology, and submitted a Marketing Authorization Application in the U.K. in December 2023.

Next Earnings

Q2 FY2026 — expected 2026-08-09

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionNWBOdiscussed_in_filing Cybersecurity
topic_mentionNWBOdiscussed_in_filing Trusted Computing
topic_mentionNWBOdiscussed_in_filing Blockchain & Crypto
topic_mentionNWBOdiscussed_in_filing Regulation
topic_mentionNWBOdiscussed_in_filing Healthcare & Bio
topic_mentionNWBOdiscussed_in_filing Platform & Ecosystem
topic_mentionNWBOdiscussed_in_filing Cybersecurity
topic_mentionNWBOdiscussed_in_filing Trusted Computing
topic_mentionNWBOdiscussed_in_filing Blockchain & Crypto
topic_mentionNWBOdiscussed_in_filing Regulation
topic_mentionNWBOdiscussed_in_filing Healthcare & Bio
topic_mentionNWBOdiscussed_in_filing Platform & Ecosystem
topic_mentionNWBOdiscussed_in_filing Cybersecurity
topic_mentionNWBOdiscussed_in_filing Trusted Computing
topic_mentionNWBOdiscussed_in_filing Blockchain & Crypto
topic_mentionNWBOdiscussed_in_filing Regulation
topic_mentionNWBOdiscussed_in_filing Healthcare & Bio
topic_mentionNWBOdiscussed_in_filing Platform & Ecosystem
topic_mentionNWBOdiscussed_in_filing Cybersecurity
topic_mentionNWBOdiscussed_in_filing Trusted Computing

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2025-03-312024-12-310001410578-25-000598EDGAR64K words
2024-03-052023-12-310001410578-24-000133EDGAR—
2023-02-282022-12-310001410578-23-000185EDGAR—
2022-03-012021-12-310001410578-22-000244EDGAR—
2021-03-312020-12-310001104659-21-044832EDGAR—
2020-03-162019-12-310001104659-20-034145EDGAR—
2019-04-022018-12-310001144204-19-017803EDGAR—
2018-04-172017-12-310001144204-18-020971EDGAR—
2017-04-172016-12-310001144204-17-020754EDGAR—
2016-03-162015-12-310001144204-16-088301EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-142025-09-300001104659-25-112676EDGAR23K words
2025-08-142025-06-300001410578-25-001825EDGAR—
2025-05-152025-03-310001410578-25-001333EDGAR—
2024-11-122024-09-300001410578-24-001879EDGAR—
2024-08-092024-06-300001410578-24-001278EDGAR—
2024-05-102024-03-310001410578-24-000741EDGAR—
2023-11-092023-09-300001410578-23-002304EDGAR—
2023-08-092023-06-300001410578-23-001633EDGAR—
2023-05-102023-03-310001410578-23-000976EDGAR—
2022-11-092022-09-300001410578-22-003073EDGAR—
2022-08-092022-06-300001410578-22-002177EDGAR—
2022-05-102022-03-310001410578-22-001218EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-01-150001104659-26-004146EDGAR1K words
2026-01-020001104659-26-000243EDGAR—
2025-11-200001104659-25-114627EDGAR—
2025-10-310001104659-25-104812EDGAR—
2025-10-300001104659-25-104427EDGAR—
2025-10-240001104659-25-102049EDGAR—
2025-10-140001104659-25-099196EDGAR—
2024-12-260001104659-24-131723EDGAR—
2024-11-010001104659-24-113553EDGAR—
2024-08-020001104659-24-085198EDGAR—

460 total filings indexed. 428 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Tags

oncology immuno-oncology cell-therapy brain-cancer-(glioblastoma-multiforme) solid-tumor-cancers

Company Identity

CIK0001072379
TickerNWBO
ExchangeOTC
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 4d8a2267aa4d9f3cef631775d9330b4223cb846b17932048f74ed336a4e51ebb
parent: 048d1089c6ae5c3150bdf1754524b0ae0ea788d905d535749ed4e0079206834c
content hash: 4ca2caa3fba9a6e42bbd536662c3522dbfac7f02f0822689c8be5174d0d787a7
signed: 2026-04-13T04:46:38.226Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf